Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-977-3 | CAS number: 112-49-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Oral:
NOAEL (29 days, gavage; rat): 250 mg/kg bw/d
Oral (read across to 2-Methoxyethanol, a possible metabolite of Triethylene glycol dimethyl ether):
NOEL (14 days, drinking water study, male mouse): 200 mg/kg bw/d
NOEL (14 days, drinking water study, female mouse): 600 mg/kg bw/d
NOAEL (13 weeks, drinking water study, male/female mouse): < 2000 ppm
NOAEL (14 days, drinking water study, male rat): 200 mg/kg bw/d
NOEL (14 days, drinking water study, female rat): 400 mg/kg bw/d
NOAEL (13 weeks, drinking water study, male rat): < 750 ppm
Inhalation read across to Diethylene glycol dimethyl ether due to structural similarities):
NOEC (2 weeks, 6h/d, nose only, female rat): 370 ppm (corresponding to 589 mg/kg bw/d); NOAEC (male rat): 110 ppm (corresponding to 175.1 mg/kg bw/d)
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Dose descriptor:
- NOAEL
- 250 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
Additional information
A 29 day oral toxicity study was performed in rats. The animals were exposed to 0, 62.5, 250 and 1000 mg/kg bw/d. All animals survived and no clinical signs were noted at any dose level. No neurological or ophthalmological effects or changes in mucosa were noted. Except of the males of the 1000 mg/kg bw/d group which showed a decreased body weight gain, the body weight gain of all animals was not affected. There were no effects upon the mean daily food and water consumption observed in all test groups. There were no changes in haematology and clinical chemistry noted at 62.5 and 250 mg/kg bw/d dose groups. At 1000 mg/kg bw/d the leucocyte count was decreased in male rats; the thrombocyte count was decreased in all animals of the high dose group. At 1000 mg/kg bw/d the bilirubin and creatinin concentration was significantly increased. Relative organ weights were within the control range with the exception of a decreased testis and epididymides weight (absolute and relative) of the males in the high dose group. The absolute and relative thymus weight was also significantly decreased in all animals of the 1000 mg/kg bw/d group. Females of the 250 mg/kg bw/d group had decreased thymus weight. The size of testes was reduced in males of the 1000 mg/kg bw/d dose group. No microscopic changes occurred at any dose level with the exception of changes of the testes, epididymides and spermatogenesis in male rats of the 1000 mg/kg bw/d dose group which caused oligo- and aspermia. In both males and females involution of thymus was observed in the high dose group.
Since there is a strong evidence that to 2-Methoxyethanol is possible a metabolite of Triethylene glycol dimethyl ether a read across to the 2 and 13-week drinking water study with 2-Methoxyethanol in rats and mice might be justified to estimate possible systemic effects of the glycol ether via oral route.
In summary, the major target organs for toxicity of 2-Methoxyethanol were testes in males (decrease in testicular and epididymal weight) and the haematopoetic system (lymphoid depletion) in both species.
To assess the inhalation toxicity of Diglyme (a structural analog to Triethylene glycol dimethyl ether), groups of 20 male and 10 female rats were exposed by nose-only inhalation 6 hours/day, 5 days/week for 2 weeks to either 0 (control), 110, 370 or 1100 ppm Diglyme. 2-Methoxyethanol was applied as positive control. Rats were sacrificed immediately following exposure, after a 14-day recovery period, or after 42 and 84 days of recovery (males only). Parameters investigated included in-life observations and body weights, clinical pathology, and histopathology with organ weights.
Exposure to Diglyme produced a variety of concentration-related changes. The most striking effect produced in all test groups was cellular injury involving the testes, seminal vesicles, epididymides and prostate. Although these effects were more severe at the higher concentrations tested, partial or complete recovery was seen by 84 days post-exposure. Changes in the haematopoetic system occurred in both sexes and involved the bone marrow, spleen, thymus, leucocytes and erythrocytes. The testicular effects of Diglyme were somewhat less pronounced than those seen with 2-Methoxyethanol. The NOEC for repeated inhalation exposure to Diglyme in female rats is 370 ppm (corresponding to 589 mg/kg bw/d). For males, the NOAEC was derived at 110 ppm (corresponding to 175.1 mg/kg bw/d).Repeated dose toxicity: via oral route - systemic effects (target organ) cardiovascular / hematological: thymus; urogenital: testes
Justification for classification or non-classification
Since no severe changes in pathology and histopathology of organs occurred in the subacute oral study in rats with Triethylene glycol dimethyl ether and in the subacute inhalation study with its structural analog Diethylene glycol dimethyl ether in rats exposed to the test substance at a concentration up to 1000 mg/kg bw/d (changes in male reproductive organs at 1000 mg/kg bw/d) and thymus atrophy was observed at dose levels 250 mg/kg bw/d, Triethylene glycol dimethyl ether does not have to be classified regarding systemic and target organ toxicity after repeated exposure according to the criteria laid down in the EU Dangerous Substances Directive (67/548/EEC) and in the EU Classification Labelling and Packaging Regulation (1272/2008/EC).
It can reasonably be deduced that the only severe effects caused by Triethylene glycol dimethyl ether are restricted to the male reproductive system (reduced testes and epididymides weight, changes in spermatogenesis etc.) and the fetal development/viability. The substance is already classified accordingly (R61 – May cause harm to the unborn child; H360 – May damage fertility or the unborn child; R62 – Possible risk of impaired fertility). No other severe systemic effects were observed after repeated applications to test animals.
Furthermore the substance is found to be not irritating to the skin and it is unlikely that higher amounts than tested in the repeated dose toxicity study will be systemically available via the skin barrier. Therefore, toxicity testing via dermal route is not scientifically necessary.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.